Tenax Therapeutics Provides 2023 Business Update

April 12, 2023

https://www.globenewswire.com/news-release/2023/04/12/2645366/0/en/Tenax-Therapeutics-Provides-2023-Business-Update.html

CHAPEL HILL, N.C., April 12, 2023 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq:TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today provided a business update outlining the Company’s product development plans for 2023.

Read more at globenewswire.com

Related news for (TENX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.